협심증 시장 규모, 점유율 및 성장 분석 : 질환 유형별, 약제 클래스별, 치료법별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Angina Market size was valued at USD 10.82 Billion in 2024 and is poised to grow from USD 11.29 Billion in 2025 to USD 15.8 Billion by 2033, growing at a CAGR of 4.3% during the forecast period (2026-2033).

The global angina market is significantly influenced by the increasing prevalence of coronary artery disease, particularly among the aging population, which drives the need for effective medical and interventional solutions. This market encompasses pharmaceuticals, diagnostic tools, and interventional devices aimed at managing symptomatic ischemia, addressing substantial healthcare challenges related to morbidity and costs. A shift has occurred from merely alleviating symptoms to employing evidence-based therapies, notably through innovations like drug-eluting stents and improved diagnostic techniques. The integration of AI enhances this landscape by enhancing detection accuracy and enabling personalized treatment plans via advanced imaging and real-time monitoring. As healthcare systems adapt to value-based care and invest in advanced diagnostics, the demand for comprehensive diagnostic-treatment pathways continues to grow, fostering significant market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Angina market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Angina Market Segments Analysis

Global angina market is segmented by disease type, drug class, treatment modality, end-user, distribution channel and region. Based on disease type, the market is segmented into Stable Angina, Unstable Angina, Microvascular Angina, Prinzmetal Angina and Others. Based on drug class, the market is segmented into Beta-Blockers, Calcium Channel Blockers, Nitrates, Angiotensin-Converting Enzyme Inhibitors, Anti-Platelet Agents and Others. Based on treatment modality, the market is segmented into Pharmacological Treatment, Invasive Procedures, Lifestyle Management and Others. Based on end-user, the market is segmented into Hospitals, Specialty Clinics, Homecare Settings and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Angina Market

The global angina market is significantly driven by the increased availability of various pharmacological classes and interventional devices, which empower clinicians to customize treatment pathways for patients. This tailored approach enhances patient compatibility and promotes ongoing adherence to therapies. Recent pharmaceutical innovations featuring agents that offer better tolerability and diverse delivery methods alleviate obstacles to long-term management. Additionally, advancements in minimally invasive procedures broaden therapeutic options for patients who had limited alternatives. Collectively, these expanded treatment choices facilitate individualized care plans, bolster clinician confidence, and promote the wider adoption of guideline-focused management strategies, thereby sustaining robust market demand.

Restraints in the Global Angina Market

The global angina market faces significant constraints primarily due to the high costs associated with innovative medications, advanced devices, and specialized procedural care. These expenses limit the affordability for both healthcare systems and patients, resulting in reduced access to newer therapeutic options. In environments with budget restrictions or unpredictable reimbursement models, healthcare providers tend to opt for older, more economical alternatives, which hampers the adoption of cutting-edge products. Additionally, the financial barriers contribute to disparities in access across different regions and demographic groups, impeding widespread acceptance and discouraging investment in supply and distribution networks. This scenario collectively stifles overall market growth potential.

Market Trends of the Global Angina Market

The Global Angina market is witnessing a significant trend towards digital remote monitoring and telehealth solutions, revolutionizing the approach to angina management. This shift enables continuous tracking of symptoms, fostering personalized care pathways and facilitating timely interventions. Healthcare professionals are increasingly utilizing wearable technology and patient-reported outcomes to customize treatment and optimize medication regimens without necessitating regular clinic visits. Integrated care models are gaining traction, enhancing patient adherence and engagement, while technology providers prioritize interoperability and intuitive interfaces. This trend not only strengthens patient-provider communication but also aligns with value-based care initiatives, markedly improving the management of chronic diseases like angina.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Angina Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Stable Angina
• Unstable Angina
• Microvascular Angina
• Prinzmetal Angina
• Others

Global Angina Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Beta-Blockers
• Calcium Channel Blockers
• Nitrates
• Angiotensin-Converting Enzyme Inhibitors
• Anti-Platelet Agents
• Others

Global Angina Market Size by Treatment Modality & CAGR (2026-2033)

• Market Overview
• Pharmacological Treatment
• Invasive Procedures
  • Angioplasty and Stenting
  • Coronary Artery Bypass Grafting
• Lifestyle Management
• Others

Global Angina Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Homecare Settings
• Others

Global Angina Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Angina Market Size & CAGR (2026-2033)

• North America (Disease Type, Drug Class, Treatment Modality, End-User, Distribution Channel)
  • US
  • Canada
• Europe (Disease Type, Drug Class, Treatment Modality, End-User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disease Type, Drug Class, Treatment Modality, End-User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disease Type, Drug Class, Treatment Modality, End-User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disease Type, Drug Class, Treatment Modality, End-User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torrent Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations